NXTS underwent a major corporate transformation including multiple name changes, a 1-for-35 reverse stock split, significant subsidiary restructuring, and a securities exchange agreement with Voice Assist, Inc.
The company has fundamentally changed its identity and structure, moving from N2OFF focusing on food preservation to Nexentis Technologies with expanded operations including energy storage and biotech subsidiaries. The reverse stock split signals potential liquidity or compliance issues, while the complex restructuring makes it difficult to assess operational continuity and strategic direction.
The company shows mixed signals with total assets growing 273% to $20.4M and cash increasing 75% to $3.8M, suggesting capital infusion or acquisition activity. However, core operations deteriorated significantly with gross profit plummeting 78% to $45K and inventory dropping 83%, indicating potential business model disruption. The 424% spike in total liabilities to $4.7M, combined with reduced R&D spending and capital expenditures, suggests the company is in a major transition period with uncertain operational momentum despite improved balance sheet resources.
Liabilities grew 424.1% — significant increase in debt or obligations, assess impact on financial flexibility.
Asset base grew 273.4% — expansion through organic growth, acquisitions, or capital deployment.
Equity base grew 237.1% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Inventory drawn down 82.7% — strong sell-through or deliberate destocking; watch for supply constraints.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Current assets grew 76.7% — improving short-term liquidity or inventory/receivables build.
Cash position surged 75.4% — strong cash generation or capital raise providing significant financial cushion.
Capex reduced 72.9% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Current liabilities surged 60.8% — significant near-term obligations; verify ability to meet short-term debt.
R&D spending cut 51.5% — could signal cost discipline or concerning reduction in innovation investment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →